Warsaw Genomicssp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-10-16
Share capital
5,000.00 PLN
Activity description

Warsaw Genomics offers genetic tests and diagnostics with medical consultations, including panels and whole-exome and whole-genome analyses using NGS. Results are interpreted using a reference database of around 100,000 genomes from the Polish population and delivered online.

Registered address
ul. Żwirki I Wigury 101, 02-089 Warszawa, Poland
Opening hours
Monday–Tuesday
8:00–10:00
Wednesday
15:30–18:30
Thursday
8:00–10:00
Friday
15:30–18:30
Phone
Social media
Electronic delivery address
AE:PL-64319-92919-EEVUS-30

Financials

Revenue history (in k)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 1056 days for 2020).

  • 2025filed
  • 202421/10/2025
  • 202330/06/2024
  • 202229/06/2023
  • 202105/09/2024
  • 202005/09/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.71mMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD 296.09kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 1.39mMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 679.22kMedianUSD 133.19kAverageUSD 3.03m

Offer

  • Genetic tests
  • Genetic panels
  • Single-gene tests
  • Genetic consultations
  • Anti-CFH antibody analysis
  • Blood collection
  • Test result translation
Certifications: ISO 9001

Website technology

Analytics and marketing
  • Google Analytics

Authorized Representatives

Krystian Arseniusz Jażdżewski – Management Board Member

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Katarzyna Anna Jażdżewskaage 50
50$675.3150%
Krystian Arseniusz Jażdżewskiage 51
50$675.3150%

Katarzyna Anna Jażdżewska and Krystian Arseniusz Jażdżewski hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2014-10-16 to 2023-10-17.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
ETG Warszawasp. z o.o.
IntodnaS.A.
Read-GeneS.A.
Medsource Polskasp. z o.o.
WPD Pharmaceuticalssp. z o.o.
Bioresearch Groupsp. z o.o.
Zakład Genetyki Sądowejsp. z o.o.
Oncotransfersp. z o.o.
GenxoneS.A.
Polbiotech Laboratoriumsp. z o.o.

Change history

DateEvent
2025-12-02Address change
2022-05-07Address change
2022-05-07PKD change
2020-02-10Address change
2014-10-16Entered in the register

FAQ

Last updated: 2026-04-09